Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-39699
BMC Cell Biol 2009 Apr 13;10:35. doi: 10.1186/1471-2121-10-35.
Show Gene links Show Anatomy links

Incomplete posttranslational prohormone modifications in hyperactive neuroendocrine cells.

Strating JR , Martens GJ .


???displayArticle.abstract???
In black-background-adapted Xenopus laevis, the intermediate pituitary melanotrope cells are hyperactive, producing large amounts of their major secretory cargo proopiomelanocortin (POMC, representing ~80% of all newly synthesised proteins), whereas in white-adapted frogs these cells are only basally active. Here we explored in the hyperactive and basally active melanotrope cells the capacity for posttranslational POMC processing events in the secretory pathway. We found that the hyperactive cells produced mainly non-complex N-glycosylated POMC, whereas in the basally active cells POMC was mostly complex N-glycosylated. Furthermore, the relative level of POMC sulphation was ~5.5-fold lower in the hyperactive than in the basally active cells. When the cargo load in the secretory pathway of the hyperactive cells was pharmacologically reduced, the relative amount of complex glycosylated POMC markedly increased. Collectively, our data show that the secretory pathway in hyperactive neuroendocrine secretory cells lacks the capacity to fully comply with the high demands for complex glycosylation and sulphation of the overload of secretory cargo. Thus, a hyperactive secretory cell may run short in providing an output of correctly modified biological signals.

???displayArticle.pubmedLink??? 19422674
???displayArticle.pmcLink??? PMC2689178
???displayArticle.link??? BMC Cell Biol


Species referenced: Xenopus laevis
Genes referenced: pomc


???attribute.lit??? ???displayArticles.show???
References [+] :
Barrios-De-Tomasi, Assessment of the in vitro and in vivo biological activities of the human follicle-stimulating isohormones. 2002, Pubmed